×

Modulation of apolipoprotein (A) expression

  • US 7,723,508 B2
  • Filed: 06/02/2004
  • Issued: 05/25/2010
  • Est. Priority Date: 06/02/2003
  • Status: Expired due to Term
First Claim
Patent Images

1. A single-stranded antisense compound 15 to 30 nucleobases in length targeted to a nucleic acid molecule encoding apolipoprotein(a), wherein said compound is at least 94% complementary to nucleotides 12380-12438 as set forth in SEQ ID NO:

  • 4.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×